Answers are grounded in this paper and cite their sources.
Case series reveals anti-inflammatory drugs successfully resolve cardiac arrhythmias during acute COVID-19, suggesting an inflammatory mechanism and targeted therapeutic approach.
Publications regarding cardiac arrhythmias associated with the new coronavirus infection (COVID-19) focus primarily on the high prevalence and symptoms of this complication. We have not found any studies on the specific treatment of arrhythmias associated with SARS-CoV2, since a standard therapeutic approach is probably implied. This observation describes a series of cases of various cardiac arrhythmias that occurred against the background of acute COVID-19 and were treated with anti-inflammatory, but not antiarrhythmic drugs. The cases are united by the occurrence of acute SARS-CoV-2 infection, the connection of relapses with inflammation symptoms, as well as the effectiveness of therapy with the main classes of anti-inflammatory drugs. A narrative review of the literature provides the rationale for the inflammatory theory of arrhythmias and sets the stage for discussion about how to integrate differentially anti-inflammatory drugs into the treatment regimen of such patients.
No takes yet. Share an insight, caveat, or question.
Sukmarova et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: